-- 欧洲锂业（ASX：EUR）周一向澳大利亚证券交易所提交的文件显示，纳斯达克上市公司Critical Metals已获得格陵兰政府批准，将Tanbreez格陵兰稀土矿剩余的50.5%股权转让给欧洲锂业，使Critical Metals在该矿的持股比例达到92.5%。 欧洲锂业同时持有Critical Metals 37.5%的股权，并表示将继续持有Tanbreez项目7.5%的少数股权。 “目前，在技术方案推进、冶金结果优异以及与承购伙伴密切合作的支持下，我们正稳步推进项目。Tanbreez不再是一个遥不可及的未来项目，而是一个正在开发中的项目。”执行主席Tony Sage表示。 周一，欧洲锂业股价上涨超过6%。
Related Articles
Oil & Energy
Market Chatter: LNG Carrier Orders Surge as Global Output Defies Iran War Tensions
Global demand for liquefied natural gas carriers is rebounding sharply in 2026, despite the ongoing US-Iran conflict, Reuters reported Monday, citing analysts and industry experts.Analysts report that surging LNG production and a transition toward high-efficiency vessels are fueling the recovery.According to the report, Shipbuilders in South Korea and China have already secured 35 new build contracts in Q1 alone.The resurgence in construction comes despite the escalating US-Iran war, which has choked the Strait of Hormuz and raised fears of a prolonged shipping downturn.However, market experts suggest that the need for modern, fuel-efficient tonnage is outweighing immediate freight rate concerns, it said.These new vessels, which cost between $250 million and $260 million and take over three years to complete, are increasingly necessary as older, steam-propelled tankers are scrapped at record rates to meet stricter global emissions regulations.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Research
Canaccord Genuity Initiates Coverage on Structure Therapeutics With Buy Rating, $101 Price Target
Structure Therapeutics (GPCR) has an average rating of Buy and mean price target of $108.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$GPCR
Research
Cantor Fitzgerald Initiates Coverage on Shattuck Labs With Overweight Rating
Shattuck Labs (STTK) has an average rating of Buy and mean price target of $12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$STTK